Mfd. by :- Pfizer (Fulfilled By : Magicine Pharma)
Magicine Pharma is registered with the Government Of NCT, India, Ministry Of Health in Government of Delhi, India, registration number DL-RAJ-122372 and as a wholesale distributor, department file No. 44208.
Brand Name:- Lorbrena
Generic Name:- Lorlatinib
Manufacturer:- Pfizer
Dosage Form:- Tablet
Strength:- 100mg
Composition:- Lorlatinib
Packaging:- 30 tablets
Indication:- Lung cancer
Storage:- Store it at room temperature
Lorbrena (lorlatinib) tablets are used in the treatment of non-small cell lung cancer, which has spread in other areas of the body. This medication works by slowing or stopping the growth of cancer cells. This medicine is used in patients who have a certain type of abnormal anaplastic lymphoma kinase (ALK) gene. Lorlatinib is given when other medicines have stopped working. Your doctor will decide the exact and proper dosing schedule. Do not stop the use of medicine without taking permission from your doctor.
Lorlatinib is a kinase inhibitor that has shown in vitro activity against several genes and protein rearrangements, including ALK, ROS1, TYK1, FER, FPS, TRKA, TRKB, TRKC, FAK, FAK2, and ACK. The gene rearrangement of ALK is a genetic alteration that drives the development of non-small cell lung cancer in several patients. Lorlatinib single oral dose absorbed in 1 to 2 hours.
This medicine may cause some serious and unwanted side effects. Which requires immediate medical attention otherwise it can also lead to higher risk. Do not forget to discuss the risk and benefits of this medication with your doctor.
Anxiety
Bleeding gums
Cough
Blurred vision
Body ache
Fever
Sore throat
Pale skin
Swelling
Chest pain
Trouble in breathing
Back Pain
Vomiting
Dizziness
Nausea
Drowsiness
Joint pain
Headache
Weakness
Fatigue
Weight gain
Diarrhea
Abdominal pain
Slow heartbeat
Fainting
Trouble in speaking
Allergic reaction
Difficulty in urination
Runny nose
Congestion
Skin rash
Burning and tingling sensations
Stiffness
Note- please contact your doctor, if you experience any side effects.
Use this medicine as prescribed by your doctor. Do not take this medicine in the wrong way and make sure to take this medication according to your dosing schedule.
In case you missed a dose, immediately contact your doctor. Do not use extra medicine to double up for the missed dose.
Emergency medical treatment is required. Please contact your medical advisor in case of an overdose.
This medicine is used to treat lung cancer. Take this medicine orally with or without food once daily. Try to take this medicine at the same time to get the most benefits of it. This medication helps to stop the growth of cancer cells in the body. Swallow the whole tablet and do not crush or chew the tablet. Take this medicine as directed by your medical advisor. Your dosage is based on your medical condition, age, and response to the treatment. Do not take 2 doses to make up for the missed dose. If you vomit after taking the medicine, do not take another dose.
Before starting treatment with the Lorbrena tablet, do not forget to discuss your previous medical history with your doctor.
Contraception
Use effective methods of contraception to prevent pregnancy while taking this medicine.
Children and adolescents
This medicine is not advisable for use in children and adolescents.
Pregnancy
Lorbrena tablets shouldn’t be used by women who are pregnant. It is recommended that this medication should be avoided during pregnancy.
Breastfeeding
This medicine is not recommended for use in breastfeeding women unless it is necessary. Please consult your doctor.
A regular blood test is necessary during treatment with this medicine.
Tell your doctor if you have allergies
Share your previous medical history with your doctor.
Don’t forget to tell your doctor if you ever had an irregular heartbeat, depression, or high cholesterol.
Do not breastfeed while taking this medicine.
Do not take this medicine if you are pregnant.
This medicine may cause eye problems such as - change in vision, pain in the eyes.
Do not crush, chew, or break the medicine.
Not safe for pregnant women.
Do not drive if you experience any sign of dizziness.
Do not take 2 doses at the same time.
Ans. This medication is used to treat non-small cell lung cancer. Which targets a protein in cancer cells and stops them from growing.
Ans. Lorlatinib is a reversible tyrosine kinase inhibitor. TKIs help to stop the growth of cancer cells. Lorlatinib blocks the abnormal ALK.
Ans. Some common side effects are:- Fever, vomiting, blurred vision, anxiety, bleeding gums, body ache, fatigue, headache, weakness, skin rash, diarrhea.
Ans. Take this medicine orally with or without food. Follow your doctor’s dosing instructions and take this medicine according to your dosing schedule.
Ans. It is available in the strength of 100mg.
Ans. In case you miss a dose try to take the medicine as soon as you remember or skip the dose and take your next dose according to your dosing schedule.
Ans. Follow your doctor’s instructions for any restriction.
Ans. Do not drive if you experience any symptoms of dizziness because it may affect your ability to drive.
Ans. This medicine is not recommended for pregnant women.
Ans. This medicine is not recommended for use in breastfeeding women unless it is necessary.
Ans. Interaction with alcohol is unknown. Please consult your doctor before consuming alcohol.
Ans. Store this medicine at room temperature.
Ans. Keep yourself hydrated and maintain good nutrition.
Interactions may change how your medication works and increase the risk for side effects. Discuss with your doctor about your previous medical history.
Apalutamide
Afatinib
Bosentan
Capmatinib
Atazanavir
Fentanyl
Indinavir
Oxycodone
Voxelotor
Hepatic impairment
Atrioventricular block
Hyperlipidemia
Severe renal impairment
Interaction with alcohol is unknown, please take permission from your doctor before consuming alcohol.
This medicine is contraindicated for concomitant use with strong CYP3A inducers.
Lorbrena tablets are not recommended for use in patients with a known allergy to lorlatinib.
This medicine is contracted in patients with known hypersensitivity to lorlatinib.
Reference
Lorlatinib: Mechanism, side effects, and dosage are available at: -https://www.cancerresearchuk.org/about-cancer/treatment/drugs/lorlatinib, https://www.webmd.com/drugs/2/drug-176414/lorlatinib-oral/details, and https://my.clevelandclinic.org/health/drugs/21330-lorlatinib-tablets